IDL Biotech AB share has been listed on Spotlight Stock Market since (26/6 2000) under the ticker (IDL B) and is traded through banks and stockbrokers.
In accordance with all regulations, IDL issues quarterly reports to the market and distributes the annual report to all shareholders. All this information is in Swedish.
The share holder’s annual meeting is usually held in Stockholm, and is announced accordingly.
Calender:
2019-02-19 IDL Biotech fourth quarter report and Year-end report 2018
We attend Redeye Life Science Day on November 21, at Haymarket City Scandic Stockholm, Hötorget 13-15, Stockholm. Charlotte Berg, CEO, presents 1 pm.
The presentation is live on www.redeye.se/live/lsday-2018. You can follow the presentation through the computer or cellphone.
Interview with Charlotte Berg
On Saturday the 17th of November, the Swedish newspaper SvD, had an interview with the CEO, Charlotte Berg.
IDL Biotech AB offentliggör prospekt för beslutad företrädesemission
Styrelsen i IDL Biotech AB (Publ) har upprättat ett prospekt med anledning av den förestående nyemissionen med företrädesrätt för IDL Biotechs aktieägare. Prospektet har idag godkänts och registrerats av Finansinspektionen.
Information from Extraordinary General Meeting
The Extraordinary meeting was held on 2018-10-26.
Redeye Life Science Day
IDL Biotech will attend Redeye Life Science Day on November 21, at Haymarket City Scandic Stockholm, Hötorget 13-15, Stockholm. Charlotte Berg, CEO, will have her presentation at 1 pm. The presentation is live on www.redeye.se/live/lsday-2018. You can follow the presentation through the computer or cellphone.
